Tezepelumab PRO Study

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

September 27, 2023

Primary Completion Date

September 20, 2025

Study Completion Date

September 20, 2025

Conditions
Asthma
Trial Locations (29)

Unknown

Research Site, Aomori

Research Site, Bunkyō City

Research Site, Fujisawa

Research Site, Fukuoka

Research Site, Fukushima

Research Site, Hamamatsu

Research Site, Hiroshima

Research Site, Iizuka

Research Site, Izumo

Research Site, Kawasaki

Research Site, Kitakyushu

Research Site, Kiyose

Research Site, Kurashiki

Research Site, Matsusaka

Research Site, Minami

Research Site, Minato

Research Site, Nagoya

Research Site, Naka

Research Site, Niigata

Research Site, Nishinomiya

Research Site, Osaka

Research Site, Sapporo

Research Site, Shinagawa City

Research Site, Shinjuku

Research Site, Shizuoka

Research Site, tabashi City

Research Site, Tennōjichō-kita

Research Site, Ube

Research Site, Yonago

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY